vs
Side-by-side financial comparison of NORTECH SYSTEMS INC (NSYS) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $30.3M, roughly 1.1× NORTECH SYSTEMS INC). NORTECH SYSTEMS INC runs the higher net margin — 3.0% vs -0.4%, a 3.3% gap on every dollar of revenue. On growth, NORTECH SYSTEMS INC posted the faster year-over-year revenue change (5.9% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $5.5M). Over the past eight quarters, Silvercrest Asset Management Group Inc.'s revenue compounded faster (2.7% CAGR vs -5.9%).
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
NSYS vs SAMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $30.3M | $32.0M |
| Net Profit | $897.0K | $-120.0K |
| Gross Margin | 16.7% | — |
| Operating Margin | 3.0% | -2.8% |
| Net Margin | 3.0% | -0.4% |
| Revenue YoY | 5.9% | -0.0% |
| Net Profit YoY | 160.7% | -107.4% |
| EPS (diluted) | $0.32 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | $32.0M | ||
| Q3 25 | $30.5M | $31.3M | ||
| Q2 25 | $30.7M | $30.7M | ||
| Q1 25 | $26.9M | $31.4M | ||
| Q4 24 | $28.6M | $32.0M | ||
| Q3 24 | $31.4M | $30.4M | ||
| Q2 24 | $33.9M | $31.0M | ||
| Q1 24 | $34.2M | $30.3M |
| Q4 25 | $897.0K | $-120.0K | ||
| Q3 25 | $-146.0K | $618.0K | ||
| Q2 25 | $313.0K | $1.9M | ||
| Q1 25 | $-1.3M | $2.5M | ||
| Q4 24 | $-1.5M | $1.6M | ||
| Q3 24 | $-739.0K | $2.3M | ||
| Q2 24 | $157.0K | $2.7M | ||
| Q1 24 | $765.0K | $3.0M |
| Q4 25 | 16.7% | — | ||
| Q3 25 | 16.5% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 12.2% | — | ||
| Q2 24 | 13.6% | — | ||
| Q1 24 | 15.9% | — |
| Q4 25 | 3.0% | -2.8% | ||
| Q3 25 | 3.1% | 4.3% | ||
| Q2 25 | 2.4% | 13.2% | ||
| Q1 25 | -6.0% | 15.4% | ||
| Q4 24 | -4.3% | 6.1% | ||
| Q3 24 | -1.5% | 14.6% | ||
| Q2 24 | 1.0% | 17.1% | ||
| Q1 24 | 3.4% | 19.5% |
| Q4 25 | 3.0% | -0.4% | ||
| Q3 25 | -0.5% | 2.0% | ||
| Q2 25 | 1.0% | 6.3% | ||
| Q1 25 | -4.9% | 7.9% | ||
| Q4 24 | -5.2% | 5.1% | ||
| Q3 24 | -2.4% | 7.4% | ||
| Q2 24 | 0.5% | 8.6% | ||
| Q1 24 | 2.2% | 9.9% |
| Q4 25 | $0.32 | $0.02 | ||
| Q3 25 | $-0.05 | $0.07 | ||
| Q2 25 | $0.12 | $0.21 | ||
| Q1 25 | $-0.48 | $0.26 | ||
| Q4 24 | $-0.51 | $0.16 | ||
| Q3 24 | $-0.27 | $0.24 | ||
| Q2 24 | $0.05 | $0.28 | ||
| Q1 24 | $0.26 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $34.5M | $50.3M |
| Total Assets | $71.9M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $44.1M | ||
| Q3 25 | $1.3M | $36.1M | ||
| Q2 25 | $652.0K | $30.0M | ||
| Q1 25 | $1.2M | $36.3M | ||
| Q4 24 | $916.0K | $68.6M | ||
| Q3 24 | $1.2M | $58.1M | ||
| Q2 24 | $1.5M | $49.9M | ||
| Q1 24 | $4.0M | $39.7M |
| Q4 25 | $34.5M | $50.3M | ||
| Q3 25 | $33.4M | $58.9M | ||
| Q2 25 | $33.4M | $64.6M | ||
| Q1 25 | $32.8M | $80.0M | ||
| Q4 24 | $34.0M | $80.7M | ||
| Q3 24 | $35.7M | $84.6M | ||
| Q2 24 | $36.1M | $85.3M | ||
| Q1 24 | $36.0M | $83.9M |
| Q4 25 | $71.9M | $166.6M | ||
| Q3 25 | $74.8M | $157.6M | ||
| Q2 25 | $74.8M | $152.7M | ||
| Q1 25 | $73.5M | $159.9M | ||
| Q4 24 | $72.4M | $194.4M | ||
| Q3 24 | $77.0M | $184.2M | ||
| Q2 24 | $76.3M | $177.6M | ||
| Q1 24 | $75.5M | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $5.6M | $18.6M |
| Free Cash FlowOCF − Capex | $5.5M | $15.0M |
| FCF MarginFCF / Revenue | 18.0% | 46.9% |
| Capex IntensityCapex / Revenue | 0.5% | 11.4% |
| Cash ConversionOCF / Net Profit | 6.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $18.6M | ||
| Q3 25 | $-92.0K | $14.6M | ||
| Q2 25 | $157.0K | $13.8M | ||
| Q1 25 | $-2.9M | $-24.7M | ||
| Q4 24 | $793.0K | $21.6M | ||
| Q3 24 | $-1.6M | $13.3M | ||
| Q2 24 | $-4.3M | $16.0M | ||
| Q1 24 | $2.8M | $-24.1M |
| Q4 25 | $5.5M | $15.0M | ||
| Q3 25 | $-242.0K | $13.8M | ||
| Q2 25 | $58.0K | $13.4M | ||
| Q1 25 | $-3.2M | $-25.1M | ||
| Q4 24 | $503.0K | $19.9M | ||
| Q3 24 | $-1.6M | $12.9M | ||
| Q2 24 | $-4.6M | $15.6M | ||
| Q1 24 | $2.1M | $-24.7M |
| Q4 25 | 18.0% | 46.9% | ||
| Q3 25 | -0.8% | 44.1% | ||
| Q2 25 | 0.2% | 43.6% | ||
| Q1 25 | -11.9% | -80.0% | ||
| Q4 24 | 1.8% | 62.2% | ||
| Q3 24 | -5.2% | 42.4% | ||
| Q2 24 | -13.5% | 50.4% | ||
| Q1 24 | 6.1% | -81.6% |
| Q4 25 | 0.5% | 11.4% | ||
| Q3 25 | 0.5% | 2.6% | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | 1.0% | 1.3% | ||
| Q4 24 | 1.0% | 5.3% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.8% | 1.1% | ||
| Q1 24 | 2.2% | 2.0% |
| Q4 25 | 6.25× | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | 0.50× | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 5.90× | ||
| Q2 24 | -27.30× | 6.00× | ||
| Q1 24 | 3.70× | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |